Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Stacie Bell"'
Autor:
Yakov Datsenko, Emmanuelle Clerisme-Beaty, Andreas Pinter, Satomi Kobayashi, Christian Boisvert-Huneault, David Trigos Herraez, Stacie Bell, Kimberley Kallsen, Tristan Gloede, Nobutaka Yagi, Steven Brunette, Frank Baehner, Peter Van de Kerkhof
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Objectives Evaluate the experiences and perceptions of patients participating in a simulated clinical trial and identify ways to enhance future patient-centric trial designs.Design International, multicentre, non-interventional, virtual clinical tria
Externí odkaz:
https://doaj.org/article/a32b8a2bbc7942da97c6757b2559c908
Autor:
Edward Hadeler, Sugandh Kumar, Samuel Yeroushalmi, Julie Hong, Elizabeth Wallace, George Han, Megan Mosca, Erin Bartholomew, Mimi Chung, Marwa Hakimi, Soumya Reddy, Jose Scher, Tina Bhutani, George Gondo, April Armstrong, Stacie Bell, Wilson Liao
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 8:11-18
Background Despite their impressive efficacy in phase 3 trials, biologic agents for psoriasis (PsO) may lose efficacy over time. The factors associated with loss of efficacy have yet to be fully elucidated. Objective We aimed to identify factors asso
Autor:
Gwenneth Feeny, Irene O. Aninye, Kelly Barta, Stacie Bell, Thea Chassin, Eunyoung Cho, Shawn G. Kwatra, Brett McReynolds, Arash Mostaghimi, Purvi Parikh, Rita O. Pichardo, Leslie Stein Lloyd
Publikováno v:
Women's Health Issues. 32:322-326
Autor:
April Armstrong, Emily Edson-Heredia, Baojin Zhu, Russel Burge, Stacie Bell, Jeffery J. Crowley, Stacy Smith
Publikováno v:
Advances in Therapy. 39:2657-2667
This cross-sectional survey was conducted with National Psoriasis Foundation (NPF) to capture treatment perspectives and expectations in patients with psoriasis (PsO) using Patient Needs Questionnaire (PNQ) of Patient Benefit Index (PBI).Adult partic
Autor:
Leah Howard, Stacie Bell
Publikováno v:
Journal of the Dermatology Nurses' Association. 14:89-92
Autor:
Christian Boisvert-Huneault, David Trigos Herraez, Andreas Pinter, Satomi Kobayashi, Stacie Bell, Kimberley Kallsen, Tristan Gloede, Nobutaka Yagi, Steven Brunette, Yakov Datsenko, Frank Baehner, Emmanuelle Clerisme-Beaty, Peter Van de Kerkhof
Publikováno v:
BMJ Open. 13:e064159
ObjectivesEvaluate the experiences and perceptions of patients participating in a simulated clinical trial and identify ways to enhance future patient-centric trial designs.DesignInternational, multicentre, non-interventional, virtual clinical trial
Autor:
Andrew Blauvelt, George C. Gondo, Stacie Bell, Cristina Echeverría, Marcus Schmitt-Egenolf, Lone Skov, Peter van de Kerkhof, Leah McCormick Howard, Bruce Strober
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. :247553032311606
Background Psoriasis severity has traditionally been categorized as mild, moderate, and severe. Commonly, cut-offs for severe disease require a body surface area (BSA) involvement of ≥10% or a Psoriasis Area Severity Index (PASI) > 10. However, cli
Autor:
Steve R. Feldman, Joel M. Gelfand, Christoph T. Ellebrecht, Erica J. Weinstein, Cassandra Calabrese, Joseph F. Merola, Dafna D. Gladman, George Gondo, Jose U. Scher, Vincent Lo Re, Mark Lebwohl, Maha N. Syed, George L. Anesi, April Armstrong, Jessica Smith, Andrew Blauvelt, Sergio Schwartzman, Anthony Ocon, Justine Fenner, James R. Treat, Christopher T. Ritchlin, Leon H Kircik, Stacie Bell, George R. Martin, Erica D. Dommasch, Sue Heydon, Abby S. Van Voorhees, Samantha Koons
Publikováno v:
Journal of the American Academy of Dermatology
Objective To provide guidance about management of psoriatic disease during the COVID-19 pandemic. Study Design A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critic
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 5:178-183
Introduction: Utilization management (UM) policies are becoming more common among commercial insurance policies. However, little research has been conducted to understand the prevalence of experiencing UM restrictions among patients with psoriatic di
Autor:
Michael Siegel, Hadiza Galadima, Clinton W. Enos, Stacie Bell, Arjun D. Saini, Abby S. Van Voorhees
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 5:100-108
Background: There are an increasing number of biologic therapies approved for the treatment of psoriasis. Previous reports have identified undertreatment as a concern in the United States. Undertreatment has been associated with decreased patient sat